Syndrome News and Research

RSS

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

In this study, scientists focused on identifying tentative cut-offs for large-scale evaluations of immune protection against SARS-CoV-2 and its variants.

3 Feb 2022

Study finds pediatric acute upper airway infection cases have increased during the Omicron variant surge

Researchers conducted a retrospective cohort study to determine if pediatric acute upper airway infection was more common during the surge of the Omicron strain of SARS-CoV-2 in the US.

3 Feb 2022

Protocol for a systematic review to evaluate the role of viral cultures for assessing airborne transmission of SARS-CoV-2

Researchers presented the protocol for a systematic review assessing viral cultures for airborne transmission of SARS-CoV-2.

3 Feb 2022

Study describes the first three days of SARS-CoV-2 infection in an ALI model of proximal airway epithelium

Researchers evaluated the initial three days of SARS-CoV-2 infection via scRNAseq dataset in humanized in vitro model.

3 Feb 2022

Evaluating vaccine effectiveness and determining differences across demographic and clinical risk factors of COVID-19

Researchers assessed the effectiveness of COVID-19 vaccines against the manifestations of SARS-CoV-2 symptoms across different cohorts.

3 Feb 2022

A relative COVID-19 survival analysis

Researchers from the University of California Riverside, Texas A & M University, Washington University, and the Medical College of Georgia have been investigating the risks of death by age due to COVID-19 infection compared to deaths by other causes in Hubei province, China.

3 Feb 2022

Red foxes susceptible to SARS-CoV-2 infection

Working towards the aim to determine the SARS-CoV-2 susceptibility of common wildlife species, the researchers in the United States have found that red fox (Vulpes vulpes) can experimentally become infected with SARS-CoV-2 and can shed virus in its oral and nasal secretions.

3 Feb 2022

Study results strongly support COVID mRNA vaccine boosters for nursing home residents

Researchers evaluate the vaccine effectiveness of mRNA booster dose in nursing home residents who completed the primary series of mRNA vaccination.

2 Feb 2022

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Researchers demonstrate that SARS-CoV-2 RBD-based nanoparticle vaccine induces neutralizing antibodies against SARS-CoV-2 variants.

2 Feb 2022

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Researchers use antigenic cartography to analyze cross-reactivity patterns of eight groups of human sera on a panel of SARS-CoV-2 variants.

2 Feb 2022

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Researchers evaluate the travel restrictions placed by nations worldwide following the emergence of the SARS-CoV-2 Omicron variant.

2 Feb 2022

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Researchers evaluate the neutralization potential of sera samples from subjects boosted with the Covaxin against the SARS-CoV-2 Omicron variant.

2 Feb 2022

Study reveals a direct correlation between fat browning and consumption of flavan 3-ols

In cold conditions, brown adipose tissue (BAT) or brown fat generates heat to keep the body warm. Compared with white adipose tissue, BAT has more mitochondria-;subcellular organelles associated with energy production-;which allows it to burn calories and produce heat by activating the mitochondrial uncoupling protein 1 (Ucp-1).

2 Feb 2022

New evidence that positive framing could improve COVID vaccine uptake globally

Researchers applied message framing techniques to the side effects associated with the AstraZeneca, Pfizer, and Moderna COVID-19 vaccines.

2 Feb 2022

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

As the global COVID-19 pandemic continues into its third year, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, is focusing on preparing for a range of other viral threats that could cause a public health emergency.

2 Feb 2022

Combined treatment strategy essential to minimize lung sequelae in COVID-19 patients

A combined treatment strategy targeting SARS-CoV-2 symptoms and severe lung tissue injury is essential to minimize lung sequelae- chronic complications resulting from COVID-19 infection, according to a review published this week in Clinical Microbiology Reviews, a journal of the American Society for Microbiology.

2 Feb 2022

Syndrome News and Research

Neutralizing antibodies against SARS-CoV-2 variants induced by homologous and heterologous COVID-19 booster vaccination

Study finds pediatric acute upper airway infection cases have increased during the Omicron variant surge

Protocol for a systematic review to evaluate the role of viral cultures for assessing airborne transmission of SARS-CoV-2

Study describes the first three days of SARS-CoV-2 infection in an ALI model of proximal airway epithelium

Evaluating vaccine effectiveness and determining differences across demographic and clinical risk factors of COVID-19

A relative COVID-19 survival analysis

Red foxes susceptible to SARS-CoV-2 infection

Study results strongly support COVID mRNA vaccine boosters for nursing home residents

Nanoparticle vaccine effective against eight SARS-CoV-2 variants in non-human primates

Antigenic map of SARS-CoV-2 variants reveals amino acid substitutions that govern immune escape and immunodominance

Analysis of SARS-CoV-2 Omicron variant-associated travel restrictions worldwide

Booster dose of Covaxin vaccine candidate neutralizes Omicron and Delta variants

Study reveals a direct correlation between fat browning and consumption of flavan 3-ols

New evidence that positive framing could improve COVID vaccine uptake globally

NIAID's new pandemic preparedness efforts aim to characterize prototype and priority pathogens

Combined treatment strategy essential to minimize lung sequelae in COVID-19 patients

Exploring protection via a 4th dose of BNT162b2 against SARS-CoV-2 Omicron variant in Israel

SARS-CoV-2 omicron variant shown to replicate less efficiently in human lungs

Researchers explore SARS-CoV-2 seroprevalence in a school community in Switzerland

Rapid antigen test for SARS-CoV-2 shows lower sensitivity

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News